Potential of NO donor furoxan as SARS-CoV-2 main protease (M(pro)) inhibitors: in silico analysis

The sharp spurt in positive cases of novel coronavirus-19 (SARS-CoV-2) worldwide has created a big threat to human. In view to expedite new drug leads for COVID-19, Main Proteases (M(pro)) of novel Coronavirus (SARS‐CoV‐2) has emerged as a crucial target for this virus. Nitric oxide (NO) inhibits th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Biomol Struct Dyn
Päätekijät: Al-Sehemi, Abdullah G., Pannipara, Mehboobali, Parulekar, Rishikesh S., Patil, Omkar, Choudhari, Prafulla B., Bhatia, M. S., Zubaidha, P. K., Tamboli, Yasinalli
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Express Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441807/
https://ncbi.nlm.nih.gov/pubmed/32643550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1790038
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia